Literature DB >> 19817065

The glycine site of NMDA receptors--a target for treatment of schizophrenia.

Joachim F Hallmayer.   

Abstract

Entities:  

Year:  2006        PMID： 19817065     DOI： 10.1007/s11920-006-0019-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  8 in total

1.  D-serine added to clozapine for the treatment of schizophrenia.

Authors:  G E Tsai; P Yang; L C Chung; I C Tsai; C W Tsai; J T Coyle
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

2.  Modulation of striatal dopamine release by glycine transport inhibitors.

Authors:  Daniel C Javitt; Audrey Hashim; Henry Sershen
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

Review 3.  Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia.

Authors:  Uriel Heresco-Levy
Journal:  Expert Opin Emerg Drugs       Date:  2005-11       Impact factor: 4.191

4.  Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.

Authors:  C J McBain; N W Kleckner; S Wyrick; R Dingledine
Journal:  Mol Pharmacol       Date:  1989-10       Impact factor: 4.436

5.  D-serine-induced nephrotoxicity: possible interaction with tyrosine metabolism.

Authors:  R E Williams; E A Lock
Journal:  Toxicology       Date:  2004-09-01       Impact factor: 4.221

6.  The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.

Authors:  Gene G Kinney; Cyrille Sur; Maryann Burno; Pierre J Mallorga; Jacinta B Williams; David J Figueroa; Marion Wittmann; Wei Lemaire; P Jeffrey Conn
Journal:  J Neurosci       Date:  2003-08-20       Impact factor: 6.167

7.  D-serine added to antipsychotics for the treatment of schizophrenia.

Authors:  G Tsai; P Yang; L C Chung; N Lange; J T Coyle
Journal:  Biol Psychiatry       Date:  1998-12-01       Impact factor: 13.382

8.  Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.

Authors:  Guochuan Tsai; Hsien-Yuan Lane; Pinchen Yang; Mian-Yoon Chong; Nicholas Lange
Journal:  Biol Psychiatry       Date:  2004-03-01       Impact factor: 13.382
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.